Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC.CRL · Entity 3398 | CEVP, Disc & Safety Assessment | October 05, 2026 | October 08, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Report date October 05, 2026 · Filed October 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 4,807 |
Ending reported balance
After 2026-10-05 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-10-05 · Exercise / conversion · Acquired 981 · Balance 5,788 Row 2 · 2026-10-05 · Sale · Disposed 981 · Balance 4,807 F1: This exercise and sale occurred pursuant to a Rule 10b5-1 Trading Plan that was adopted on March 4, 2026. |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $208.44 · Expires 2034-05-31 | Direct | 2,944 |
Reported balance
After 2026-10-05 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-10-05 · Exercise / conversion · Disposed 981 · Balance 2,944 |
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 9,680 |
Reported balance
Holding disclosure · report date 2026-10-05 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 9,680 |
| Common StockSEC Table I · non-derivative | Indirectby Karpathos Investments LLC | 28,510 |
Reported balance
Holding disclosure · report date 2026-10-05 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 28,510 |
Filing footnotes · ownership attribution and instrument terms
F1: This exercise and sale occurred pursuant to a Rule 10b5-1 Trading Plan that was adopted on March 4, 2026.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 29, 2024 Filed Mar 25, 2024 22:52 UTC Amendment | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantCommon Stock | 2,070 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-011126 · form4a.xml · nonDerivative · entry 2 Parisotto Shannon M · CIK 0001952784 · CEVP, Disc & Safety Assessment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,922 F1 · shares: Reflects shares of common stock issued following the achievement of performance goals set forth in performance share unit awards originally granted on May 28, 2021. Read SEC document |
| May 29, 2023 Filed May 31, 2023 17:21 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 110 | $194.12 | $21,353.20 |
DisclosureSEC source: 0001127602-23-017131 · form4.xml · nonDerivative · entry 4 Parisotto Shannon M · CIK 0001952784 · CEVP, Disc & Safety Assessment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,288 Read SEC document |
| May 28, 2023 Filed May 31, 2023 17:21 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 71 | $194.12 | $13,782.52 |
DisclosureSEC source: 0001127602-23-017131 · form4.xml · nonDerivative · entry 3 Parisotto Shannon M · CIK 0001952784 · CEVP, Disc & Safety Assessment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,398 Read SEC document |
| May 27, 2023 Filed May 31, 2023 17:21 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 105 | $194.12 | $20,382.60 |
DisclosureSEC source: 0001127602-23-017131 · form4.xml · nonDerivative · entry 2 Parisotto Shannon M · CIK 0001952784 · CEVP, Disc & Safety Assessment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,469 Read SEC document |
| May 26, 2023 Filed May 31, 2023 17:21 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantStock Options (Right to Buy) · Derivative | 4,078 | $194.12 Strike: $194.12 | $791,621.36 |
DisclosureSEC source: 0001127602-23-017131 · form4.xml · derivative · entry 5 Parisotto Shannon M · CIK 0001952784 · CEVP, Disc & Safety Assessment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,078 Underlying: Common Stock · 4,078 shares Expires 2033-05-26 F2 · shares: Stock Options vest as follows: 1,019 on May 26, 2024, 1,020 on May 26, 2025, 1,019 on May 26, 2026 and 1,020 on May 26, 2027. Read SEC document |
| May 26, 2023 Filed May 31, 2023 17:21 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantCommon Stock | 1,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-017131 · form4.xml · nonDerivative · entry 1 Parisotto Shannon M · CIK 0001952784 · CEVP, Disc & Safety Assessment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,574 F1 · shares: Restricted Stock Units vest as follows: 425 on May 26, 2024, 425 on May 26, 2025, 425 on May 26, 2026 and 425 on May 26, 2027. Read SEC document |
| February 22, 2023 Filed Feb 22, 2023 22:02 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 136 | $243.60 | $33,129.60 |
DisclosureSEC source: 0001127602-23-006520 · form4.xml · nonDerivative · entry 1 Parisotto Shannon M · CIK 0001952784 · CEVP, Disc & Safety Assessment 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,874 Read SEC document |
| February 16, 2023 Filed Feb 21, 2023 22:39 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionStock Options (Right to Buy) · Derivative | 4,558 | $0.00 Strike: $109.34 | $0.00 |
DisclosureSEC source: 0001127602-23-006261 · form4.xml · derivative · entry 13 Parisotto Shannon M · CIK 0001952784 · CEVP, Disc & Safety Assessment 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,558 shares Expires 2023-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2023 Filed Feb 21, 2023 22:39 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 155 | $257.05 | $39,843.06 |
DisclosureSEC source: 0001127602-23-006261 · form4.xml · nonDerivative · entry 11 Parisotto Shannon M · CIK 0001952784 · CEVP, Disc & Safety Assessment 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,010 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. F10 · price: This transaction was executed in multiple trades at prices ranging from $257.015 to $257.085. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 16, 2023 Filed Feb 21, 2023 22:39 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 994 | $256.20 | $254,661.91 |
DisclosureSEC source: 0001127602-23-006261 · form4.xml · nonDerivative · entry 10 Parisotto Shannon M · CIK 0001952784 · CEVP, Disc & Safety Assessment 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,165 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. F9 · price: This transaction was executed in multiple trades at prices ranging from $255.92 to $256.605. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 16, 2023 Filed Feb 21, 2023 22:39 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 1,674 | $255.48 | $427,671.34 |
DisclosureSEC source: 0001127602-23-006261 · form4.xml · nonDerivative · entry 9 Parisotto Shannon M · CIK 0001952784 · CEVP, Disc & Safety Assessment 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,159 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. F8 · price: This transaction was executed in multiple trades at prices ranging from $254.955 to $255.9. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 16, 2023 Filed Feb 21, 2023 22:39 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 533 | $254.22 | $135,500.97 |
DisclosureSEC source: 0001127602-23-006261 · form4.xml · nonDerivative · entry 8 Parisotto Shannon M · CIK 0001952784 · CEVP, Disc & Safety Assessment 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,833 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. F7 · price: This transaction was executed in multiple trades at prices ranging from $253.915 to $254.55. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 16, 2023 Filed Feb 21, 2023 22:39 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 451 | $253.42 | $114,292.10 |
DisclosureSEC source: 0001127602-23-006261 · form4.xml · nonDerivative · entry 7 Parisotto Shannon M · CIK 0001952784 · CEVP, Disc & Safety Assessment 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,366 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. F6 · price: This transaction was executed in multiple trades at prices ranging from $252.99 to $253.895. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 16, 2023 Filed Feb 21, 2023 22:39 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 264 | $252.28 | $66,601.31 |
DisclosureSEC source: 0001127602-23-006261 · form4.xml · nonDerivative · entry 6 Parisotto Shannon M · CIK 0001952784 · CEVP, Disc & Safety Assessment 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,817 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. F5 · price: This transaction was executed in multiple trades at prices ranging from $252.155 to $252.72. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 16, 2023 Filed Feb 21, 2023 22:39 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 19 | $251.53 | $4,778.98 |
DisclosureSEC source: 0001127602-23-006261 · form4.xml · nonDerivative · entry 5 Parisotto Shannon M · CIK 0001952784 · CEVP, Disc & Safety Assessment 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,081 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| February 16, 2023 Filed Feb 21, 2023 22:39 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 158 | $250.56 | $39,588.23 |
DisclosureSEC source: 0001127602-23-006261 · form4.xml · nonDerivative · entry 4 Parisotto Shannon M · CIK 0001952784 · CEVP, Disc & Safety Assessment 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,100 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. F4 · price: This transaction was executed in multiple trades at prices ranging from $250.195 to $250.69. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 16, 2023 Filed Feb 21, 2023 22:39 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 194 | $248.16 | $48,142.92 |
DisclosureSEC source: 0001127602-23-006261 · form4.xml · nonDerivative · entry 3 Parisotto Shannon M · CIK 0001952784 · CEVP, Disc & Safety Assessment 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,258 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. F3 · price: This transaction was executed in multiple trades at prices ranging from $248.05 to $248.19. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 16, 2023 Filed Feb 21, 2023 22:39 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 116 | $246.02 | $28,538.00 |
DisclosureSEC source: 0001127602-23-006261 · form4.xml · nonDerivative · entry 2 Parisotto Shannon M · CIK 0001952784 · CEVP, Disc & Safety Assessment 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,452 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $245.91 to $246.54. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 16, 2023 Filed Feb 21, 2023 22:39 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionCommon Stock | 4,558 | $109.34 | $498,371.72 |
DisclosureSEC source: 0001127602-23-006261 · form4.xml · nonDerivative · entry 1 Parisotto Shannon M · CIK 0001952784 · CEVP, Disc & Safety Assessment 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,568 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 27, 2023 Filed Jan 30, 2023 23:07 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 1,309 | $244.49 | $320,037.41 |
DisclosureSEC source: 0001127602-23-002707 · form4.xml · nonDerivative · entry 2 Parisotto Shannon M · CIK 0001952784 · CEVP, Disc & Safety Assessment 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,010 Read SEC document |
| January 27, 2023 Filed Jan 30, 2023 23:07 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantCommon Stock | 4,820 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-002707 · form4.xml · nonDerivative · entry 1 Parisotto Shannon M · CIK 0001952784 · CEVP, Disc & Safety Assessment 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,319 F1 · shares: Reflects shares of common stock issued following the achievement of performance goals set forth in performance share unit awards originally granted on May 29, 2020. Read SEC document |
| November 15, 2022 Filed Nov 17, 2022 22:22 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionStock Options (Right to Buy) · Derivative | 2,279 | $0.00 Strike: $109.34 | $0.00 |
DisclosureSEC source: 0001127602-22-025976 · form4.xml · derivative · entry 4 Parisotto Shannon M · CIK 0001952784 · CEVP, Disc & Safety Assessment 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,558 Underlying: Common Stock · 2,279 shares Expires 2023-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 15, 2022 Filed Nov 17, 2022 22:22 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 2,279 | $249.90 | $569,522.10 |
DisclosureSEC source: 0001127602-22-025976 · form4.xml · nonDerivative · entry 2 Parisotto Shannon M · CIK 0001952784 · CEVP, Disc & Safety Assessment 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,499 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| November 15, 2022 Filed Nov 17, 2022 22:22 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionCommon Stock | 2,279 | $109.34 | $249,185.86 |
DisclosureSEC source: 0001127602-22-025976 · form4.xml · nonDerivative · entry 1 Parisotto Shannon M · CIK 0001952784 · CEVP, Disc & Safety Assessment 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,778 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.